Skip to main content
. 2020 Oct 31;7(12):ofaa534. doi: 10.1093/ofid/ofaa534

Table 3.

SARS-CoV-2 Test Positivity (Virus and/or Antibody) in Relation to Self-Reported Recent or Prior Symptoms of COVID-19 (n = 3904)a

Characteristic All Participants (n = 3904) Participants With at Least One Symptom (n = 1435)
Reported symptom Odds Ratio (95% CI)
Feverb
 Felt feverish but did not take temperature 0.97 (0.64–1.46) 0.95 (0.64–1.42)
 Recorded temperature over 100°F 2.58 (1.75–3.81) 2.47 (1.68–3.64)
Cough 1.03 (0.70–1.50) 0.96 (0.65–1.41)
Shortness of breath or difficulty breathing 0.86 (0.55–1.33) 0.86 (0.56–1.31)
Vomiting 0.82 (0.40–1.68) 0.81 (0.40–1.66)
Diarrhea/multiple watery stools 1.23 (0.81–1.85) 1.19 (0.79–1.78)
Loss of smell 5.13 (2.85–9.24) 4.97 (2.78–8.90)
Loss of taste 4.01 (2.30–7.01) 4.00 (2.30–6.94)
Body ache 1.39 (0.95–2.04) 1.30 (0.88–1.90)
Headaches 1.19 (0.86–1.66) 1.06 (0.74–1.52)
Other symptomsc 0.52 (0.35–0.78) 0.52 (0.35–0.76)

Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

a Results significant at P < .05 are indicated in bold font.

b Reference group: no fever

c Includes the following: fatigue, nausea, loss of appetite, conjunctivitis, nasal and sinus congestion, runny nose, sneezing, chest tightness, abdominal pain, and rash.